AtriCure (NASDAQ:ATRC) Price Target Raised to $66.00
AtriCure (NASDAQ:ATRC – Free Report) had its price target lifted by Canaccord Genuity Group from $61.00 to $66.00 in a report released on Thursday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities analysts also recently issued reports on ATRC. Oppenheimer raised their price […]
AtriCure (NASDAQ:ATRC – Free Report) had its price target lifted by Canaccord Genuity Group from $61.00 to $66.00 in a report released on Thursday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities analysts also recently issued reports on ATRC. Oppenheimer raised their price […]
